Skip to main content
Caplight Logo









Nuwacell Biotechnologies Co., Ltd.

Nuwacell Biotechnologies Co., Ltd.

Private
HefeiHealthcare & Life Scienceshttps://en.nuwacell.com/

Last Round

Series A

Sep 13, 2022

Company Overview

Nuwacell Biotechnologies Co., Ltd. is a biotechnology company that develops widely accessible iPSC-derived cell therapy products.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

induced pluripotent stem cellsiPSCsiPSC technologycell therapyoff-the-shelf cell therapyallogeneic cell therapyregenerative medicineiPSC cell therapycontract development and manufacturingCDMOimmunotherapyiPSC CDMOiNK cell therapyiMSC therapyiPSC cell bankculture reagents

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nuwacell Biotechnologies Co., Ltd. Comparables

Compare Nuwacell Biotechnologies Co., Ltd. with similar companies based on industry and business-model similarity.

Nuwacell Biotechnologies Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
HebeCell
85%
iRegene Therapeutics
83%
iCamuno Biotherapeutics
81%

Nuwacell Biotechnologies Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 13, 2022

Nuwacell Biotechnologies Co., Ltd. Investors

Notable investors and investment history

Nuwacell Biotechnologies Co., Ltd. investors
InvestorRounds
China Merchants GroupSeries A
Legend CapitalSeries A
GF Venture CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 13, 2022

    Led by China Merchants Group and Legend Capital

Nuwacell Biotechnologies Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Nuwacell Biotechnologies Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Nuwacell Biotechnologies Co., Ltd.'s valuation, stock price, and market status.

Is Nuwacell Biotechnologies Co., Ltd. a public or private company?

Nuwacell Biotechnologies Co., Ltd. is a private company.

What is the current stock price of Nuwacell Biotechnologies Co., Ltd.?

Nuwacell Biotechnologies Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.

How much is Nuwacell Biotechnologies Co., Ltd. worth (valuation)?

Valuation information for Nuwacell Biotechnologies Co., Ltd. is not publicly available.

Can I buy Nuwacell Biotechnologies Co., Ltd. stock?

Nuwacell Biotechnologies Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Nuwacell Biotechnologies Co., Ltd.'s last funding round?

Nuwacell Biotechnologies Co., Ltd.'s most recent funding round was Series A on September 13, 2022.

Who are the main investors in Nuwacell Biotechnologies Co., Ltd.?

Key investors in Nuwacell Biotechnologies Co., Ltd. include China Merchants Group, Legend Capital.

Will Nuwacell Biotechnologies Co., Ltd. IPO soon?

No public IPO plans have been announced for Nuwacell Biotechnologies Co., Ltd..

How can I track Nuwacell Biotechnologies Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nuwacell Biotechnologies Co., Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHefei
Year Founded2016
Last FundingSep 13, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?